Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral N (2 (phosphoryl) 1 phenylethyl) amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112209965A details a high-yield rhodium-catalyzed asymmetric hydrogenation route for chiral beta-aminophosphine precursors, offering significant supply chain and cost advantages.